ReviewTranslational and clinical pharmacology2025

A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025.

Seoyoung Koo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.